<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03043235</url>
  </required_header>
  <id_info>
    <org_study_id>2237</org_study_id>
    <nct_id>NCT03043235</nct_id>
  </id_info>
  <brief_title>Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity</brief_title>
  <official_title>Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study will examine how ethnic/racial background, body composition (%body fat),&#xD;
      and the location of body fat affect the ability of the hormone insulin to promote uptake of&#xD;
      blood sugar in persons who are 19 to 45 years of age. When insulin is ineffective in&#xD;
      promoting blood sugar uptake, this condition is termed &quot;insulin resistance.&quot; Insulin&#xD;
      resistance plays a major role in the development of chronic metabolic diseases (such as type&#xD;
      2 diabetes, cardiovascular disease, and cancer), many of which differ with race. Previous&#xD;
      studies suggest that insulin resistance is higher in African-Americans (AA) vs.&#xD;
      European-Americans (EA). However, results from these studies remain unclear due to different&#xD;
      testing measures used for insulin resistance as well as differences in body fat between&#xD;
      individuals. Results from this research study may help explain why insulin resistance differs&#xD;
      with genetic background and may guide development of personalized treatment strategies with&#xD;
      implications for several chronic metabolic diseases (e.g., type 2 diabetes, cardiovascular&#xD;
      disease, and cancer).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Insulin resistance plays a major role in the etiology of chronic metabolic diseases, many of&#xD;
      which differ with race/ethnicity. Previous studies using mainly indirect methods suggest that&#xD;
      insulin sensitivity is lower in AA vs. EA. Our preliminary data using the reference standard&#xD;
      glucose clamp indicate that in lean individuals, insulin sensitivity is lower among AA, while&#xD;
      in obese individuals, insulin sensitivity is higher among AA. We hypothesize that this&#xD;
      race/body mass index (BMI) interaction may be explained in part by significantly lower&#xD;
      visceral and hepatic fat accumulation in AA. Conversely, based on our preliminary data, we&#xD;
      hypothesize that inherently greater oxidative stress impairs insulin sensitivity even in AA,&#xD;
      explaining lower insulin sensitivity in lean AA vs. EA. We propose to test these hypotheses&#xD;
      by prospectively comparing skeletal muscle and hepatic insulin sensitivity in healthy lean,&#xD;
      overweight, and obese AA and EA using the hyperinsulinemic isoglycemic glucose clamp.&#xD;
      Analysis of ancestral genes will permit simultaneous assessment of the contribution of&#xD;
      ancestry to main outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 8, 2014</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hyperinsulinemic isoglycemic glucose clamp</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">126</enrollment>
  <condition>Insulin Sensitivity</condition>
  <condition>Fat; Liver</condition>
  <arm_group>
    <arm_group_label>African American Females</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>African American Males</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caucasian Females</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caucasian Males</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA will be used to identify ancestry. This information is needed to understand why African&#xD;
      Americans and Caucasians have different risks for developing certain diseases.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        African American and Caucasian Males and Females between 19-45 years old&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  African American or Caucasian&#xD;
&#xD;
          -  Body Mass Index 19-45&#xD;
&#xD;
          -  Do NOT have diabetes&#xD;
&#xD;
          -  Exercise less than 2 hours per week&#xD;
&#xD;
          -  Are willing to travel to UAB for 2 screens and 4 testing visits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Any major medical conditions or medications that interfere with study outcomes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Gower, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>February 2, 2017</study_first_submitted>
  <study_first_submitted_qc>February 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2017</study_first_posted>
  <last_update_submitted>July 12, 2018</last_update_submitted>
  <last_update_submitted_qc>July 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Barbara Gower</investigator_full_name>
    <investigator_title>Prinicipal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

